Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Jan 25 | KALA Kala Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 7.63 | 5,779 | 44.09 k | 280,076 |
6 Jan 25 | KALA Kala Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 22,100 | 0.00 | 285,855 |
6 Jan 25 | KALA Kala Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 7.53 | 99,500 | 749.24 k | 99,500 |
26 Jun 24 | KALA Kala Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 4.75 | 15,168 | 72.05 k | 263,755 |
8 Jun 24 | AKRO Akero Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 23.02 | 26,000 | 598.52 k | 26,000 |
6 Jun 24 | THRD Third Harmonic Bio | Director Stock Option Common Stock | Grant | Acquire A | No | No | 13.85 | 20,000 | 277.00 k | 20,000 |
5 Jun 24 | AVTE Aerovate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 18.9 | 12,500 | 236.25 k | 12,500 |